Patient Portal

Click below to see our affiliate companies.

D&K Supplements | Vascuwave ED

Recent News

13Oct, 2009

Pros and Cons to Prostate Surgeries

By: | Tags:

Study Finds Pro and Cons to Prostate Surgeries By RONI CARYN RABIN Published: October 13, 2009 Prostate cancer patients who chose minimally invasive surgery rather than more extensive operations to remove the prostate were less likely to experience complications like pneumonia, but reported higher rates of long-term problems, including impotence and incontinence, according to one of the largest studies to compare outcomes to date. Patients achieved similar rates of cancer control regardless of which surgery they had, the analysis found. The study, in Wednesday’s Journal of the American Medical Association, […]
READ MORE

12Sep, 2008

Prostate Cancer Treatment Chart Released

By: | Tags:

Prostate Cancer Treatment Option Facts “Prostate Cancer Treatment Options – The Facts” is a comprehensive factual description of 17 mainstream prostate cancer treatment options that was premiered at the Prostate Cancer Research Institute’s annual international conference in Los Angeles on September 6th, 2008. Sarasota, Florida – September 12, 2008 — Prostate cancer is the second most common type of cancer found in men, and one in six men will develop prostate cancer during their lifetime. In response and dedicated to their mission, Dattoli Prostate Cancer Treatment Center has published a […]
READ MORE

27Aug, 2008

Regrets After Prostate Surgery

By: | Tags:

August 27, 2008, 9:26 am Regrets After Prostate Surgery By TARA PARKER-POPE One in five men who undergoes prostate surgery to treat cancer later regrets the decision, a new study shows. And surprisingly, regret is highest among men who opt for robotic prostatectomy, a minimally invasive surgery that is growing in popularity as a treatment. The research, published in the medical journal European Urology, is the latest to suggest that technological advances in prostate surgery haven’t necessarily translated to better results for the men on which it is performed. It […]
READ MORE

19Jun, 2008

Tools for Fighting Prostate Cancer

By: | Tags:

Experience and knowledge are tools for fighting prostate cancer Published: Thursday, June 19, 2008 at 2:31 a.m. Regarding Sunday’s front-page article, “As prostate drug gets new look, it stirs new debate”: I’d like to comment. Having spent more than 25 years studying prostate cancer, and treating more than 10,000 men, I am well aware of the dilemmas presented by new drugs (such as finasteride — Proscar) and treatment options (such as high-intensity focused ultrasound or proton therapy). Regarding the question of using Proscar and its counterpart Avodart: These are the […]
READ MORE

7Apr, 2008

A Doctor’s Cancer Journey

By: | Tags:

It cost him $100,000 — but it saved his life April 07, 2008 Denise Davy The Hamilton Spectator BURLINGTON (Apr 7, 2008) When a Burlington doctor discovered he had prostate cancer, he went in search of the best medical care money could buy. It took him to the United States and cost him $100,000, but balanced against his chances of survival if he’d stayed in Canada, it was an easy decision. Dr. Tom Johnson, 54, works at Halton Family Health Care and was healthy and fit, despite his tedious 75-hour […]
READ MORE

27Aug, 2007

Dual Therapy

By: | Tags:

Dual therapy can control high-risk prostate cancer David Douglas Mon Aug 27, 2007 10:14pm EDT NEW YORK (Reuters Health) – High rates of tumor control over the long term are possible with combination treatment using external beam radiation followed by brachytherapy in high-risk prostate cancer patients, according to researchers. Health “These patients have been followed longer than any other treatment group reported in the prostate specific antigen era,” lead investigator Dr. Michael Dattoli told Reuters Health. Prostate specific antigen (PSA) has become a standard tumor marker for prostate cancer, with […]
READ MORE

26Aug, 2007

Purging Prostate Cancer

By: | Tags:

The latest technology at Dattoli Cancer Center & Brachytherapy Research Institute By: Virginia ‘Ginya’ Carnahan, APR, CPRC Michael Dattoli, MD, and Richard Sorace, MD, PhD, have shared a challenge for more than two decades. The radiation oncologists have sought a better way to treat prostate cancer – a definitive treatment that will defeat the cancer while not destroying the man’s quality of life after treatment. The reported incidence (and additional whispered stories) of incontinence and impotence in men following radical prostatectomy was just unacceptable to these physicians. As technology has […]
READ MORE

13Jul, 2005

Abstract Accepted for Prestigious Meeting

By: | Tags:

Wednesday, July 13, 2005 Abstract Accepted for Prestigious Meeting Results of ongoing research into the efficacy of treating certain prostate cancers with combination therapy consisting of Palladium-103 brachytherapy (seed implant) and supplemental beam radiation, has been accepted for presentation at the annual meeting of the prestigious American Society of Therapeutic Radiation Oncology (ASTRO). The meeting will be held October 16-20, 2005 in Denver. Michael Dattoli, MD and Richard Sorace, MD have documented long-term (13 year actuarial) results of the combination therapy used in treating 282 patients with high risk disease. […]
READ MORE

17Oct, 2004

Clinical Outcomes Reported at ASTRO

By: | Tags:

Sunday, October 17, 2004 Clinical Outcomes Reported at ASTRO Demonstrate Effectiveness of Palladium-103 Brachytherapy in Treatment of Aggressive Prostate Cancer BUFORD, Ga., Oct 17, 2002- Theragenics Corporation(R) (NYSE: TGX) announced today the results of new studies confirming the effectiveness of TheraSeed(R), a Palladium-103 (Pd-103) brachytherapy product, in patients with aggressive cancer who previously were considered poor candidates for seeding. The findings, revealed in several presentations at the October 6-10, 2002, ASTRO (American Society of Therapeutic Radiology and Oncology) meeting in New Orleans, La., also reinforce the effectiveness of Pd-103 treatment […]
READ MORE

1Jun, 2004

Next Generation Prostate Ultrasound Studies

By: | Tags:

Tuesday, June 1, 2004 Next Generation Prostate Ultrasound Studies Debut at Dattoli Cancer Center Accurately diagnosing prostate cancer is essential to successful treatment. The widely used PSA blood test is only an indication of the relative health of the prostate gland, and as recent studies indicate, a low PSA can give a false sense of security to as many as 15% of men reporting them. The walnut-sized gland, deep in the man’s lower abdomen presents physical exam challenges because of its position in close proximity to many critical structures – […]
READ MORE

Call 1-877-DATTOLI or Send Us a Message Now